반응형
구분 보고서 (영문)
제약/바이오/임상시험 EMA CHMP Decision for Nezglyal Recommends Refusal of Marketing Authorization
Novartis Will See Modest Boost to Blood Cancer Portfolio with MorphoSys Acquisition
Epetraborole Phase III Enrollment Pause Sets Back NTM Late-Stage Pipeline
Beacon Therapeutics Unveils Promising Interim Results for Gene Therapy AGTC-501
ViiV Healthcare and GSK’s Cabenuva Could Reduce Poor Treatment Adherence in HIV
Biogen Discontinues Aduhelm to Focus on Leqembi for Alzheimer’s Disease
질환별 2023–24 Seasonal Flu Activity Remains Elevated
Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032
Will Smart Technology Revolutionize Drug Delivery for Ulcerative Colitis Patients?
Central Nervous System Takes the Lead in Global Drug Withdrawals
Burden of Dental Diseases Rises Sharply in the UK
컨퍼런스/심포지엄/학회/기타 Conference Organizing Tool - ADPD 2024
Conference Organizing Tool – European Lupus Meeting (ELM) 2024 - Interim 
반응형
반응형
구분 보고서 (영문)
제약/바이오/임상시험 Exelixis's Cabometyx Advances mCRPC Treatment with Big Trial Validation Questions
Arexvy’s Potential Label Expansion Will Provide Competitive Advantage in RSV Space
Novo Nordisk to Acquire CMO Giant Catalent for $16.5 Billion
New Hope for GSK’s Once Potential ADC Blockbuster Blenrep
Novo to Buy Catalent: The Backlash Begins
PCSK9 Inhibitor Alirocumab Proves Effective in Pediatric Familial Hypercholesterolemia
Tozorakimab Flunks Efficacy Endpoint in Phase IIb for DKD
질환별 Artificial Intelligence Shows Improved Accuracy of Ovarian Cancer Diagnosis
Ovarian Cancer: Opportunity Assessment and Forecast
Invasive Meningitis Cases Declined Post Vaccine Rollout in Western Australia
Age, Gender and Heart Failure: Understanding the Connection
Blood Tests for Alzheimer’s Could Significantly Improve Diagnosis in Patients
Premature Labor (PL): Competitive Landscape
컨퍼런스/심포지엄/학회/기타 Alternative Therapies Are Needed to Combat the Impending Threat of AMR
International Gaucher Alliance Marks 30th Year, Unveils 5-Year Strategic Plan to 2029
Conference Organizing Tool – ECCO 2024

반응형
반응형
구분 보고서 (영문)
제약/바이오/임상시험 Bladder Cancer-Focused CG Oncology Files for IPO
At Least Three Oncology 2023 Brand Launches Have Blockbuster Potential
Contract Manufacturing: Opportunities and Threats – January 2024
Bio/Pharmaceutical Outsourcing Report, January 2024
Contract Service Agreements – January 2024
January Quarterly Contract Manufacturing Mergers, Acquisitions, and Financing – Q1 2024
Gilead’s Trodelvy Falters as Next Major ADC in Phase III NSCLC Trial
Moderna Leads the Development of mRNA Vaccines in Infectious Diseases
Cell and Gene Therapies – Top Pharmaceutical Industry Trend to Watch for 2024
FDA Awarded Record Number of Review Designations to CRISPR Drugs in 2023
질환별 Follow-Up Analysis Reinforces Opdivo’s Use in PD-L1 Urothelial Carcinoma Patients
Substance Use Disorder Linked with Increased Cardiac Mortality
Increased Global Deaths from Fungal Disease Highlights Disease Management Obstacles
Enlarged Prostate Decreases Quality of Life in Men
2024 Kicks Off with a Surge in Clinical Trials Tackling Women’s Infertility
Could MicroRNAs Offer a New Approach to the Diagnosis of Lupus Nephritis in Systemic Lupus Erythematosus?
The US Dominates Ongoing/Planned Trials Researching Skin Cancer
컨퍼런스/심포지엄/학회/기타 Merck Is on the Lookout for More Opportunities Within Immunology
AstraZeneca Posts Positive Preliminary Results for Imfinzi in TACE-Eligible Hepatocellular Carcinoma
Germany’s Ministry of Health Refutes Accusations of Worsening Market Conditions

 

반응형
반응형

구분 보고서 (영문)
제약/바이오/
임상시험
Major Depressive Disorder Market to Reach $9.6 Billion Across 8MM by 2029
Clinical Trials: What to Expect in 2024 – a Preview of Trials Planned to Initiate and Estimated to Complete
Female Contraceptives Market Is Still in Need of Therapeutics with Better Safety Profiles
Eli Lilly and Innovent’s Obesity Drug Mazdutide Achieves Positive Phase III Results
AbbVie’s Produodopa Holds Potential to Become the First-Choice Pump for Advanced Parkinson’s
Zosurabalpin Shows Promise in the Fight Against Antibacterial Resistance
XORTX Therapeutics Looking to Enter CKD Space with Lead Product XRX-008
EU Access to Oncology Medicines Lags Behind in the Netherlands
질환별 Acute Ischemic Stroke: Competitive Landscape
Hyperinsulinemia: Competitive Landscape
ADHD Unmet Needs Present Opportunities for the Development of New Non-stimulants
Brazilian Study Explores Tuberculosis Risk Among Household Contacts
Obesity Disease Management Needs to Be Revolutionized
Revolutionizing Lung Health: the Promise of PATROL for Early Detection
ECDC Report Suggests Respiratory Infections Could Surge This Winter
Vaccine Hesitancy Causes Cases of Measles to Rise in the UK
Major Depressive Disorder: 68-Market Analysis and Sales Forecast
Urgent Call for Earlier Diagnosis to Improve Gaucher Disease Patient Outcomes
컨퍼런스/
심포지엄/
학회/기타
Global Risk Report (Quarterly Update) Q3 2023
Amgen Showcases Exciting Potential in the Obesity Space at JPM24
반응형

+ Recent posts